Counselors in Liberal, KS Accepting Medicare

9 Counselors found. Showing 1 - 9

Dan William Miller, LPC, LCPC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 504 N Kansas Ave Ste B, Liberal, KS 67901 Phone: 620-604-5111

Mrs. Sarah M. Mersdorf-foreman, LMSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 333 W 15th St, Liberal, KS 67901 Phone: 620-624-8171    Fax: 620-624-0114

Dr. Brenda Leona Ridgeway, PH.D., LCAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 504 N Kansas Ave Ste B, Liberal, KS 67901 Phone: 620-604-5274

Mrs. Sherrie Mashell Harrison, LMSW LAC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1539 N Webster Ave, Liberal, KS 67901 Phone: 620-391-1261

Brian Edward Rixon, MA, LCPC, LCAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 333 W 15th St, Liberal, KS 67901 Phone: 620-624-8171    Fax: 620-624-0114

Dr. William J Bernhardt-purdy, LMSW, LPC, LMAC, DSW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 220 Cornell Ave, Liberal, KS 67901 Phone: 620-366-9782

Edgar Enrique Herrera Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 500 N Kansas Ave, Liberal, KS 67901 Phone: 620-604-5111

Mary E Deboard, L.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 333 W 15th St, Liberal, KS 67901 Phone: 620-624-8171    Fax: 620-624-0114

Mrs. Amy R Martin, LCPC-KS, LPC-AR Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 333 W 15th St, Liberal, KS 67901 Phone: 620-624-8171

News Archive

Ocera Therapeutics presents Phase 2 proof-of-concept study results of AST-120 in non-constipating IBS

Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.

Shire announces findings from Phase 3 study data with Vyvanse

Shire plc, the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse®. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.

Study shows how a protein in the brain could protect against Alzheimer's

Research shows that white blood cells in the human brain are regulated by a protein called CD33-a finding with important implications in the fight against Alzheimer's disease, according to a new study by University of Alberta chemists.

Officials stake out positions as debt deadline looms

As lawmakers pushed on Sunday to devise a plan to raise the debt limit and keep the government from risking default, Democrats and Republicans spent the morning offering reassurances and staking out their positions. Administration officials and lawmakers are expected to meet throughout the day to consider plans for reducing the deficit ahead of the Aug.

Read more Medical News

› Verified 7 days ago